Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Front Immunol ; 15: 1361062, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38440737

RESUMEN

Introduction: Antiphospholipid syndrome (APS) is an autoimmune thrombotic disease with various systemic presentations. This study aimed to identify homogeneous groups of patients based on a non-supervised hierarchical cluster analysis and assess the rate of relapse associated with antinuclear antibodies (ANA). Methods: This retrospective observational study enrolled patients, over a 90-month period, who had APS as defined by the 2006 Sydney classification criteria, and for whom ANA workup was performed. Agglomerative unsupervised hierarchical clustering was conducted to classify patients into subgroups using 24 variables reflecting a range of clinical and biological baseline features associated with APS. Results: Hundred and seventy-four patients were included and were categorized into four phenotypes. Cluster 1 (n=73) associated mostly middle-aged men with risk factors for cardiovascular disease. Obstetrical APS with low-risk thrombosis made up cluster 2 (n=25). Patients with venous thromboembolism (VTE), microvascular findings and double/triple positive APL antibodies (50%) were represented in cluster 3 (n=33). Whereas cluster 4 (n=43) characterized a predominantly female subpopulation with positive ANA and systemic lupus (n=23) that exhibited a high thrombotic risk and more frequent relapses (n=38) (p<0.001). Conclusions: This study identified four homogenous groups of patients with APS listed as: i) cardiovascular and arterial risk, ii) obstetrical, iii) VTE and microvascular, and iv) ANA-positive APS. We found that ANA-positivity was associated with higher rates of relapse. Applying ANA status to classification criteria could constitute a novel approach to tailoring management for APS, based on phenotypic patterns and risk assessment.


Asunto(s)
Síndrome Antifosfolípido , Enfermedades Autoinmunes , Tromboembolia Venosa , Masculino , Persona de Mediana Edad , Humanos , Femenino , Síndrome Antifosfolípido/diagnóstico , Anticuerpos Antinucleares , Análisis por Conglomerados , Fenotipo , Recurrencia
2.
JAMA Dermatol ; 160(1): 114-115, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-37910114

RESUMEN

This case report describes a woman in her 20s who presented with an itchy erythematous-papulo-pustular eruption of the scalp for 3 months with progressive centrifugal extension to the face and was diagnosed with Ofuji disease.


Asunto(s)
Anticuerpos Monoclonales Humanizados , Eosinofilia , Foliculitis , Enfermedades Cutáneas Vesiculoampollosas , Humanos , Eosinofilia/diagnóstico , Eosinofilia/tratamiento farmacológico , Foliculitis/diagnóstico , Foliculitis/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA